Upadacitinib as induction and maintenance therapy for moderately to severely active ulcerative colitis: results from three phase 3, multicentre, double-blind, randomised trials

Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis

Brian G. Feagan, Paul Rutgeerts, Bruce E. Sands et al. · New England Journal of Medicine · 2013 · 2.9K citations · Full text

Pharmacy, Immunology, Pharmacotherapy +15

Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis

William J. Sandborn, Chinyu Su, Bruce E. Sands et al. · New England Journal of Medicine · 2017 · 1.7K citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +14

ACG Clinical Guideline: Ulcerative Colitis in Adults

David T. Rubin, Ashwin N. Ananthakrishnan, Corey A. Siegel et al. · The American Journal of Gastroenterology · 2019 · 1.6K citations

Medicine, Clinical Sciences, Internal Medicine +16

Adalimumab Induces and Maintains Clinical Remission in Patients With Moderate-to-Severe Ulcerative Colitis

William J. Sandborn, Gert Van Assche, Walter Reinisch et al. · Gastroenterology · 2011 · 1.3K citations

Life Sciences, Clinical Sciences, Immunology +16

Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis

Bruce E. Sands, William J. Sandborn, Remo Panaccione et al. · New England Journal of Medicine · 2019 · 1.2K citations · Full text

Pharmacy, Immunology, Pharmacotherapy +17